ns-MRAs and Biomarkers: The NT-proBNP Connection

CME
10/01/2025

Listen "ns-MRAs and Biomarkers: The NT-proBNP Connection "

Descargar episodio Ver en sitio original

Episode Synopsis



Guest: Muthiah Vaduganathan, MD, MPH

Guest: Orly Vardeny, MD



Discover the transformative potential of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in optimizing care for patients with the Cardiovascular-Kidney-Metabolic syndrome. Emerging data presented at EASD, HFSA, ASN and AHA, highlight their ability to improve cardiorenal outcomes in the spectrum of the Cardiovascular-Kidney-Metabolic syndrome. By integrating ns-MRAs into individualized treatment plans, healthcare professionals can offer their patients advanced care backed by cutting-edge research.

More episodes of the podcast CME

Updates in Major Depressive Disorder with Insomnia 07/11/2025
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages 15/10/2025
Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis 03/10/2025
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers 30/09/2025
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers 30/09/2025
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers 30/09/2025
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer 30/09/2025
From Resistance to Response: Evolving Strategies in MDD Management 26/09/2025
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 26/09/2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025 26/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA